Fredrick Clerie has been named vice president of quality assurance and regulatory affairs at Illumina, the company said this week. Clerie will report to Joel McComb, senior vice president and general manager of Illumina's Life Sciences Business Unit.
Prior to joining Illumina, Clerie served as vice president of global quality assurance and regulatory affairs for the Diagnostics Division of Bayer HealthCare, now Siemens Diagnostics. Clerie's previous role was vice president of quality assurance for the Laboratory Testing Segment of Bayer HealthCare.
Clerie holds a BA in biology and chemistry from Greenville College and an MS in biochemistry from the University of Illinois.
Invitrogen has named Mark Smedley, the firm’s global head of operations, to lead the integration team for its $6.7 billion acquisition of Applied Biosystems.
Invitrogen said in a statement that Smedley has 20 years of experience in the life sciences and pharmaceuticals industries, including a stint at drug giant Novartis, where he “led several global multi-business, multi-billion dollar integrations.”